Pharmaceutical Industries News

Buy or sell stocks: Sumeet Bagadia has recommended three stocks to buy on Monday — Sun Pharma, ICICI Bank, and Ambuja Cements

Sun Pharmaceutical Industries Q3 FY24 Results Live: Revenue increased by 10.14% YoY & profit increased by 16.52% YoY

Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for $43 per share in cash, aiming to gain complete control over its subsidiary

In today's trade, Lupin's shares soared nearly 7%, hitting a new all-time high of ₹1,404 apiece after Japanese brokerage firm Nomura raised the target price on the stock to ₹1,593 apiece from the previous ₹1,290, maintaining its 'buy' recommendation.

Pharma companies – Cipla, Torrent Pharma, Eris Lifesciences, and JB Chemicals, among others – have increased their chronic presence, focused on new product launches, and entered into new therapies.

Indian stock market: As long as Nifty 50 sustains above 19,500, the outlook remains positive. Moving above 19,800 can further validate this positive outlook. However, if it falls below 19,500, it may attract further selling pressure up to 19,200 level

Motilal Oswal upgrades Cipla's rating to 'Buy', while Dr Reddy's, Zydus Lifesciences, Lupin, Aurobindo Pharma, and Torrent Pharma maintain their ratings. Sun Pharma retains 'Buy' rating.

Sun Pharma’s India formulation sales rose 5.1% to ₹3,560.4 crore. US formulation sales at $471 million were up 12% YoY. US sales accounted for over 33% of total consolidated sales of the company.

Q1 results 2023: 63 listed companies include Bharti Airtel, Varun Beverages, Eicher Motors, Cummins India, Lupin, MRF, Deepak Nitrite, LIC Housing Finance, Radico Khaitan, etc.

Day trading stocks: Market experts have recommended six stocks to buy today —Ashok Leyland, Glenmark Pharmaceuticals, Sun Pharmaceuticals, SAIL, Dabur, and Bharat Electronics.